Zinc Supplementation Effect on Immune Recovery in HIV Patients
Last updated on April 2022Recruitment
- Recruitment Status
- Unknown status
Inclusion Criteria
- Patients with body mass index over 18.5 kg/m2.
- Patients with two viral loads less than 40 copies/ml (viral supression) and a stable or inferior CD4 lymphocyte count.
- Patients without opportunistic diseases.
- ...
- Patients with body mass index over 18.5 kg/m2.
- Patients with two viral loads less than 40 copies/ml (viral supression) and a stable or inferior CD4 lymphocyte count.
- Patients without opportunistic diseases.
- Adults suffering from HIV/AIDS, over 18 years of age with first- and second-line antiretroviral therapy.
Exclusion Criteria
- Pregnant women.
- Patients who are unwilling to participate.
- Hospitalized patients with cognitive disability evaluated by a doctor.
- ...
- Pregnant women.
- Patients who are unwilling to participate.
- Hospitalized patients with cognitive disability evaluated by a doctor.
- Patients taking zinc supplements.
Summary
- Conditions
- AIDS
- HIV
- Immunological Deficiency
- Inadequate Immune Recovery
- Viral Replication
- Type
- Interventional
- Design
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
GOAL: To assess the effect of zinc supplementation in the natural history of HIV, emphasizing on the immunological recovery of patients in a health care provider program in Medellín in 2012. METHODS: A prospective, randomized, double-blind, controlled clinical trial will be conducted. The selected g...
GOAL: To assess the effect of zinc supplementation in the natural history of HIV, emphasizing on the immunological recovery of patients in a health care provider program in Medellín in 2012. METHODS: A prospective, randomized, double-blind, controlled clinical trial will be conducted. The selected group will consist of male and female patients over 18 years of age, who comply with the inclusion criteria, with digital clinical history, in an HIV/AIDS program of a health care provider in Medellín. They will receive zinc supplements for 3 months. A comparison will be made between the immunological recovery among those patients taking the zinc supplement and those who are not. The CD4 lymphocytes value will be taken as an independent variable.
Inclusion Criteria
- Patients with body mass index over 18.5 kg/m2.
- Patients with two viral loads less than 40 copies/ml (viral supression) and a stable or inferior CD4 lymphocyte count.
- Patients without opportunistic diseases.
- ...
- Patients with body mass index over 18.5 kg/m2.
- Patients with two viral loads less than 40 copies/ml (viral supression) and a stable or inferior CD4 lymphocyte count.
- Patients without opportunistic diseases.
- Adults suffering from HIV/AIDS, over 18 years of age with first- and second-line antiretroviral therapy.
Exclusion Criteria
- Pregnant women.
- Patients who are unwilling to participate.
- Hospitalized patients with cognitive disability evaluated by a doctor.
- ...
- Pregnant women.
- Patients who are unwilling to participate.
- Hospitalized patients with cognitive disability evaluated by a doctor.
- Patients taking zinc supplements.
Tracking Information
- NCT #
- NCT02162797
- Collaborators
- IPS Fundación SIAM
- Investigators
- Principal Investigator: Heidy Contreras, PhC. Researcher Principal Investigator: Marcela Duque, MD. Researcher Principal Investigator: Elsa Vásquez, Biologist Researcher
- Heidy Contreras, PhC. Researcher Principal Investigator: Marcela Duque, MD. Researcher Principal Investigator: Elsa Vásquez, Biologist Researcher
Get Well Soon